Scopia Holdings/Member Matthew Sirovich reports 9.99% in PAVmed (PAVM)

Rhea-AI Filing Summary

Scopia Holdings LLC and Matthew Sirovich reported beneficial ownership stakes in PAVmed Inc. Scopia Holdings LLC beneficially owns 630,118 shares of Common Stock (CUSIP 70387R502), representing 9.87%. Mr. Matthew Sirovich is reported as beneficially owning 637,670 shares, representing 9.99%, which reflects his control over the Scopia holdings plus 7,552 additional shares. The reporting address is c/o Scopia Capital Management LP, and the signature date provided is 04/13/2026.

Insights

Governance Analyst

Large passive ownership reported just below and at the 10% threshold.

Scopia Holdings LLC is shown with 630,118 shares (9.87%) and Matthew Sirovich with 637,670 shares (9.99%). The filing attributes Sirovich with voting and dispositive power over the LLC's position and an additional 7,552 shares.

Because the stakes approach the statutory 10% reporting threshold, subsequent filings could disclose changes in voting power or status; any future change crossing 10% would alter reporting obligations and market disclosure. Filing dates tied to the signature are 04/13/2026.

Key Figures

Scopia Holdings shares: 630,118 shares Matthew Sirovich shares: 637,670 shares CUSIP: 70387R502 +2 more

5 metrics

Scopia Holdings shares 630,118 shares beneficially owned, 9.87%

Matthew Sirovich shares 637,670 shares beneficially owned, 9.99%

CUSIP 70387R502 PAVmed Common Stock identifier

Reporting date 04/13/2026 signature date on Schedule 13G

Additional shares attributed to Sirovich 7,552 shares shares beyond Scopia Holdings that Sirovich may control

Key Terms

beneficially owned, sole dispositive power, CUSIP

3 terms

beneficially owned regulatory

"Scopia Holdings LLC beneficially owns 630,118 shares of Common Stock"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole Dispositive Power 630,118.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

CUSIP financial

"Common Stock, par value $0.001 per share 70387R502"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PAVmed Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

70387R502

(CUSIP Number)

03/27/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 70387R502

1

Names of Reporting Persons

Scopia Holdings LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 630,118.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 630,118.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

630,118.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP Number(s): 70387R502

1

Names of Reporting Persons

Matthew Sirovich

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 637,670.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 637,670.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

637,670.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PAVmed Inc.
(b)	Address of issuer's principal executive offices: 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017.
Item 2.
(a)	Name of person filing: Scopia Holdings LLC Matthew Sirovich
(b)	Address or principal business office or, if none, residence: c/o Scopia Capital Management LP 152 West 57th Street, 33rd Floor New York, NY 10019
(c)	Citizenship: Scopia Holdings LLC is a Delaware limited partnership Matthew Sirovich is a United States citizen
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP Number(s): 70387R502
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Scopia Holdings LLC beneficial owns 630,118 shares of Common Stock. Mr. Sirovich may be deemed to have the power to direct the vote and disposition of the shares owned by Scopia Holdings LLC and, therefore, may be deemed to beneficially own such shares. Mr. Sirovich may also be deemed to have the power to direct the vote and disposition of an additional 7,552 shares and therefore may be deemed to beneficially own such shares.
(b)	Percent of class: Scopia Holdings LLC - 9.87% Matthew Sirovich - 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Scopia Holdings LLC - 630,118 shares Matthew Sirovich - 637,670 shares
	(ii) Shared power to vote or to direct the vote: 0 shares
	(iii) Sole power to dispose or to direct the disposition of: Scopia Holdings LLC - 630,118 shares Matthew Sirovich - 637,670 shares
	(iv) Shared power to dispose or to direct the disposition of: 0 shares
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Scopia Holdings LLC

Signature:	Matthew Sirovich
Name/Title:	Member
Date:	04/13/2026

Matthew Sirovich

Signature:	Matthew Sirovich
Name/Title:	Reporting Person
Date:	04/13/2026

FAQ

What stake does Scopia Holdings LLC report in PAVmed (PAVM)?

Scopia Holdings LLC reports beneficial ownership of 630,118 shares (9.87%). The filing lists voting and dispositive power for those shares and identifies the position under CUSIP 70387R502 with reporting signed on 04/13/2026.

How many PAVmed shares does Matthew Sirovich beneficially own?

Matthew Sirovich is reported as beneficially owning 637,670 shares (9.99%). This total includes the 630,118 shares held by Scopia Holdings LLC plus an additional 7,552 shares he is deemed to control, per the filing.

Does the filing state who has voting and dispositive power for the shares?

Yes. The filing states Scopia Holdings LLC has sole voting and dispositive power over 630,118 shares. It also states Mr. Sirovich may direct vote and disposition of those shares and an additional 7,552 shares, giving him sole power over 637,670 shares.

What address is listed for the reporting person in the Schedule 13G?

The address is c/o Scopia Capital Management LP, 152 West 57th Street, 33rd Floor, New York, NY 10019. That address is provided as the principal business office for the reporting party in the filing.

What is the reported CUSIP for PAVmed common stock in this filing?

The filing lists CUSIP 70387R502 for PAVmed Inc. common stock. The CUSIP appears on the cover information accompanying the ownership disclosures in the filing.